GLENMARK LIFE SCIENCES LIMITED |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 829.8 INR | -1.18% |
|
-2.77% | +26.28% |
| 05-15 | Granules India posts Q4 revenue fall on weak paracetamol sales, price erosion | RE |
| 04-25 | Transcript : Glenmark Life Sciences Limited, Q4 2024 Earnings Call, Apr 25, 2024 |
Quotes 5-day view
End-of-day quote NSE India S.E.| 2024-06-14 | 2024-06-18 | 2024-06-19 | 2024-06-20 | 2024-06-21 | |
|---|---|---|---|---|---|
| Last | 853.35 ₹ | 857.1 ₹ | 845.6 ₹ | 839.65 ₹ | 829.75 ₹ |
| Volume | 49 189 | 42 754 | 51 917 | 25 997 | 43 071 |
| Change | -0.55% | +0.44% | -1.34% | -0.70% | -1.18% |
| Opening | 862.00 | 865.00 | 857.10 | 854.95 | 847.00 |
| High | 871.00 | 865.00 | 864.60 | 854.95 | 847.00 |
| Low | 850.00 | 847.10 | 838.55 | 835.00 | 825.80 |
Performance
| 1 day | -1.18% | ||
| 1 week | -2.77% | ||
| Current month | -0.78% | ||
| 1 month | -0.30% | ||
| 3 months | +10.09% | ||
| 6 months | +28.57% | ||
| Current year | +26.28% | ||
| 1 year | +45.85% |
Volumes
marketsDaily volume
43 071
Avg. Volume 20 sessions
69 699
Avg. Volume 20 sessions INR
57 832 745.25
Avg. Volume 20 sessions USD
692 315.79
Record volume 1
20 222 310
Record volume 2
3 967 075
Record volume 3
2 882 997
Capital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (INR)
101 612 195 222
Capitalization (USD)
1 216 399 589
Net sales (INR)
22 832 140 000
Net sales (USD)
273 323 548
Number of employees
1 824
Sales / Employee (INR)
12 517 621
Sales / Employee (USD)
149 848
Free-Float
15.72 %
Free-Float capitalization (INR)
15 975 298 511
Free-Float capitalization (USD)
191 240 298
Average Daily Capital Traded
0.06%
Highs and lows
1 week
825.80
865.00
1 month
755.95882.00
Current year
655.65906.00
1 year
557.10906.00
3 years
370.00906.00
5 years
370.00906.00
10 years
370.00906.00
Indicators
Moving average 5 days
845.09
Moving average 20 days
845.22
Moving average 50 days
829.68
Moving average 100 days
824.94
Price spread / (MMA5)
+1.85%
Price spread / (MMA20)
+1.86%
Price spread / (MMA50)
-0.01%
Price spread / (MMA100)
-0.58%
STIM
RSI 9 days
38.33
RSI 14 days
45.22
Sector Comparison - Other Pharmaceuticals
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| -1.18% | -2.77% | +26.28% | +45.85% | 1.22B | ||
| -0.24% | +0.62% | +51.63% | +93.12% | 796B | ||
| -0.59% | -0.31% | +41.51% | +81.93% | 628B | ||
| +0.66% | +2.21% | -5.10% | -10.19% | 358B | ||
| +0.81% | +0.96% | +19.90% | +14.95% | 331B | ||
| -1.01% | +1.07% | +9.95% | +24.00% | 301B | ||
| +0.60% | -0.30% | +17.66% | +7.52% | 244B | ||
| +1.12% | +2.10% | +3.39% | -8.02% | 228B | ||
| -0.36% | -1.07% | +10.75% | +4.36% | 214B | ||
| -0.56% | +3.19% | +6.99% | +34.18% | 165B | ||
| 0.00% | +0.76% | -3.65% | -28.38% | 157B | ||
| -0.56% | +1.38% | -2.38% | -10.24% | 117B | ||
| +3.18% | +8.62% | -12.76% | -9.53% | 88.04B | ||
| +2.17% | +1.77% | -18.28% | -35.79% | 85B | ||
| -1.17% | -0.34% | +10.26% | +17.66% | 82.33B | ||
| -0.26% | +0.52% | +40.75% | +17.31% | 65.3B | ||
| Average | +0.16% | +1.15% | +12.31% | +14.92% | ||
| Weighted average by Cap. | +0.04% | +0.94% | +21.61% | +34.64% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Monthly variations
Annual change
| 2024 | +26.28% | ||
| 2023 | +56.38% | ||
| 2022 | -33.42% | ||
| 2021 | -15.69% |
- Stock Market
- Equities
- GLS Stock
- Quotes Glenmark Life Sciences Limited
